Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B A Bergelson

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Chest|December 1, 1995
Gender differences in clinical evaluation and triage in coronary artery diseaseB A Bergelson, C L Tommaso
American Heart Journal|February 1, 1995
Left main coronary artery disease: assessment, diagnosis, and therapyB A Bergelson, C L Tommaso
Catheterization and Cardiovascular Diagnosis|January 1, 1996
Gender differences in percutaneous interventional therapy of coronary artery diseaseB A Bergelson, C L Tommaso
American Heart Journal|November 5, 1997
Abrupt vessel closure: changing importance, management, and consequencesB A Bergelson, R F Fishman, C L Tommaso
Clinical Science (London, England : 1979)|April 1, 1996
Effects of hypercholesterolaemia on physiological recruitment of coronary vascular reserve in swineB A Bergelson, T K Yu, N A Ruocco
Clinical and Experimental Hypertension (New York, N.Y. : 1993)|October 1, 1995
Augmentation of coronary blood flow by ACE inhibition: role of angiotensin and bradykininN A Ruocco, B A Bergelson, T K Yu, et al.
Journal of the American College of Cardiology|December 11, 1992
Invasive versus conservative strategy after thrombolytic therapy for acute myocardial infarction in patients with antecedent angina. A report from Thrombolysis in Myocardial Infarction Phase II (TIMI II)N A Ruocco, B A Bergelson, A K Jacobs, et al.
Journal of the American College of Cardiology|July 1, 1989
Antecedent angina: a predictor of residual stenosis after thrombolytic therapyB A Bergelson, N A Ruocco, T J Ryan, et al.
The American Journal of Cardiology|December 25, 1992
Prediction of risk for hemodynamic compromise during percutaneous transluminal coronary angioplastyB A Bergelson, A K Jacobs, L A Cupples, et al.
The American Journal of Cardiology|May 15, 1996
Effects of platelet glycoprotein IIb/IIIa receptor blockade by a chimeric monoclonal antibody (abciximab) on acute and six-month outcomes after percutaneous transluminal coronary angioplasty for acute myocardial infarction. EPIC investigatorsJ Lefkovits, R J Ivanhoe, R M Califf, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Chest|December 1, 1995
Gender differences in clinical evaluation and triage in coronary artery diseaseB A Bergelson, C L Tommaso
American Heart Journal|February 1, 1995
Left main coronary artery disease: assessment, diagnosis, and therapyB A Bergelson, C L Tommaso
Catheterization and Cardiovascular Diagnosis|January 1, 1996
Gender differences in percutaneous interventional therapy of coronary artery diseaseB A Bergelson, C L Tommaso
American Heart Journal|November 5, 1997
Abrupt vessel closure: changing importance, management, and consequencesB A Bergelson, R F Fishman, C L Tommaso
Clinical Science (London, England : 1979)|April 1, 1996
Effects of hypercholesterolaemia on physiological recruitment of coronary vascular reserve in swineB A Bergelson, T K Yu, N A Ruocco
Clinical and Experimental Hypertension (New York, N.Y. : 1993)|October 1, 1995
Augmentation of coronary blood flow by ACE inhibition: role of angiotensin and bradykininN A Ruocco, B A Bergelson, T K Yu, et al.
Journal of the American College of Cardiology|December 11, 1992
Invasive versus conservative strategy after thrombolytic therapy for acute myocardial infarction in patients with antecedent angina. A report from Thrombolysis in Myocardial Infarction Phase II (TIMI II)N A Ruocco, B A Bergelson, A K Jacobs, et al.
Journal of the American College of Cardiology|July 1, 1989
Antecedent angina: a predictor of residual stenosis after thrombolytic therapyB A Bergelson, N A Ruocco, T J Ryan, et al.
The American Journal of Cardiology|December 25, 1992
Prediction of risk for hemodynamic compromise during percutaneous transluminal coronary angioplastyB A Bergelson, A K Jacobs, L A Cupples, et al.
The American Journal of Cardiology|May 15, 1996
Effects of platelet glycoprotein IIb/IIIa receptor blockade by a chimeric monoclonal antibody (abciximab) on acute and six-month outcomes after percutaneous transluminal coronary angioplasty for acute myocardial infarction. EPIC investigatorsJ Lefkovits, R J Ivanhoe, R M Califf, et al.
Pageof 2